Scroll Top

2025 News Release

Gain Therapeutics Inc.
2024 News Release 2023 News Release 2022 News Release 2021 News Release 2020 News Release 2019 News Release 2025 News Release
Clear Filters
2024 News Release
December 23, 2024
Gain Therapeutics Initiates Phase 1b Clinical Trial of Lead Candidate GT-02287 in People with GBA1 and Idiopathic Parkinson’s Disease
Read More
December 11, 2024
Gain Therapeutics To Present At Biotech Showcase 2025
Read More
November 14, 2024
Gain Therapeutics Reports Financial Results for Third Quarter 2024 and Provides Corporate Update
Read More
October 23, 2024
Gain Therapeutics Presents Data at 36áµ—Ê° EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics Demonstrating Identification of Allosteric Inhibitors Targeting DDR2
Read More
October 15, 2024
Gain Therapeutics Announces Poster Presentation at 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Read More
October 9, 2024
Gain Therapeutics to Present at Michael J. Fox Foundation’s 16th Annual Parkinson’s Disease Therapeutics Conference
Read More
October 7, 2024
Gain Therapeutics Presents Preclinical GT-02287 Data at Neuroscience 2024
Read More
October 3, 2024
Gain Therapeutics to Participate at Upcoming Investor Conferences
Read More